<DOC>
	<DOC>NCT00310609</DOC>
	<brief_summary>The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the aortic arch and cerebral branches. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography.</brief_summary>
	<brief_title>MagnevistÂ® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches</brief_title>
	<detailed_description>This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of the trial.</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Cardiovascular Abnormalities</mesh_term>
	<criteria>Has known or suspected disease of the aortic arch and cerebral branches Is scheduled for Xray angiography Has any contraindication to magnetic resonance imaging Is scheduled for any procedure before the Xray angiography Had previous bilateral intervention (surgery, bypass) of the arteries of interest</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Structural abnormalities of the aortic arch and cerebral branches</keyword>
</DOC>